[96a5a0]: / output / allTrials / identified / NCT05099562_identified.json

Download this file

545 lines (545 with data), 22.5 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
{
"info": {
"nct_id": "NCT05099562",
"official_title": "Precision Acupuncture in the Treatment of Peripheral Neuropathy After Taxanes Chemotherapy in Breast Cancer",
"inclusion_criteria": "1. The patient was at least 18 years old and had reported grade 1 or higher neuropathic symptoms for more than 2 weeks;\n2. Patients were screened for eligibility by the investigator prior to enrollment, including verification of baseline neuropathic symptoms.\n3. Patients had a diagnosis of stage I, II, or IIIA breast cancer;\n4. Have completed at least 2 weeks of chemotherapy;\n5. Higher scores indicate more severe symptoms;\n6. Voluntarily participate in the clinical trial and sign the informed consent form after informed consent (patients voluntarily accept the treatment and give informed consent);\n7. Eastern Cooperative Oncology Group (ECOG ) score of physical condition (0-1);\n8. Patients with previous local recurrence were eligible;\n9. The basic indexes were consistent, and the blood routine and ECG were normal.\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years\nMust have maximum age of 75 Years",
"exclusion_criteria": "1. patients with needle phobia;\n2. Low platelet count (<50 000); co-morbidity with a bleeding disorder; comorbidity with thyroid dysfunction; pregnancy; haemoglobin levels <10 g/dl and haematocrit <30; anaemia on active pharmacological treatment or receiving blood transfusion or steroids;\n3. having metastatic or recurrent disease, history of preexisting peripheral neuropa- thy prior to chemotherapy, uncontrolled seizure disorder, unstable cardiac disease or myocardial infarction within 6 months prior to study entry;\n4. Being pregnant or nursing, or having used acupuncture for peripheral neuropathy within 6 months prior to study entry;\n5. Life expectancy <6 months;\n6. Lymphedema of limbs;",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "1. The patient was at least 18 years old and had reported grade 1 or higher neuropathic symptoms for more than 2 weeks;",
"criterions": [
{
"exact_snippets": "at least 18 years old",
"criterion": "age",
"requirements": [
{
"requirement_type": "N/A",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
]
},
{
"exact_snippets": "reported grade 1 or higher neuropathic symptoms",
"criterion": "neuropathic symptoms",
"requirements": [
{
"requirement_type": "severity",
"expected_value": {
"operator": ">=",
"value": 1,
"unit": "grade"
}
}
]
},
{
"exact_snippets": "neuropathic symptoms for more than 2 weeks",
"criterion": "duration of neuropathic symptoms",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">",
"value": 2,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "2. Patients were screened for eligibility by the investigator prior to enrollment, including verification of baseline neuropathic symptoms.",
"criterions": [
{
"exact_snippets": "verification of baseline neuropathic symptoms",
"criterion": "neuropathic symptoms",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "3. Patients had a diagnosis of stage I, II, or IIIA breast cancer;",
"criterions": [
{
"exact_snippets": "diagnosis of stage I, II, or IIIA breast cancer",
"criterion": "breast cancer",
"requirements": [
{
"requirement_type": "stage",
"expected_value": [
"I",
"II",
"IIIA"
]
}
]
}
]
},
{
"line": "4. Have completed at least 2 weeks of chemotherapy;",
"criterions": [
{
"exact_snippets": "completed at least 2 weeks of chemotherapy",
"criterion": "chemotherapy",
"requirements": [
{
"requirement_type": "completion",
"expected_value": {
"operator": ">=",
"value": 2,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "5. Higher scores indicate more severe symptoms;",
"criterions": [
{
"exact_snippets": "Higher scores indicate more severe symptoms",
"criterion": "symptom severity",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "higher scores"
}
]
}
]
},
{
"line": "6. Voluntarily participate in the clinical trial and sign the informed consent form after informed consent (patients voluntarily accept the treatment and give informed consent);",
"criterions": [
{
"exact_snippets": "Voluntarily participate in the clinical trial",
"criterion": "voluntary participation",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "sign the informed consent form",
"criterion": "informed consent form",
"requirements": [
{
"requirement_type": "signed",
"expected_value": true
}
]
}
]
},
{
"line": "7. Eastern Cooperative Oncology Group (ECOG ) score of physical condition (0-1);",
"criterions": [
{
"exact_snippets": "Eastern Cooperative Oncology Group (ECOG ) score of physical condition (0-1)",
"criterion": "ECOG score",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 1,
"unit": "N/A"
}
]
}
}
]
}
]
},
{
"line": "8. Patients with previous local recurrence were eligible;",
"criterions": [
{
"exact_snippets": "Patients with previous local recurrence",
"criterion": "previous local recurrence",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "9. The basic indexes were consistent, and the blood routine and ECG were normal.",
"criterions": [
{
"exact_snippets": "basic indexes were consistent",
"criterion": "basic indexes",
"requirements": [
{
"requirement_type": "consistency",
"expected_value": true
}
]
},
{
"exact_snippets": "blood routine ... normal",
"criterion": "blood routine",
"requirements": [
{
"requirement_type": "status",
"expected_value": "normal"
}
]
},
{
"exact_snippets": "ECG ... normal",
"criterion": "ECG",
"requirements": [
{
"requirement_type": "status",
"expected_value": "normal"
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be FEMALE",
"criterions": [
{
"exact_snippets": "Must be FEMALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "female"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
},
{
"line": "Must have maximum age of 75 Years",
"criterions": [
{
"exact_snippets": "maximum age of 75 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 75,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "1. patients with needle phobia;",
"criterions": [
{
"exact_snippets": "patients with needle phobia",
"criterion": "needle phobia",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "2. Low platelet count (<50 000); co-morbidity with a bleeding disorder; comorbidity with thyroid dysfunction; pregnancy; haemoglobin levels <10 g/dl and haematocrit <30; anaemia on active pharmacological treatment or receiving blood transfusion or steroids;",
"criterions": [
{
"exact_snippets": "Low platelet count (<50 000)",
"criterion": "platelet count",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": "<",
"value": 50000,
"unit": ""
}
}
]
},
{
"exact_snippets": "co-morbidity with a bleeding disorder",
"criterion": "bleeding disorder",
"requirements": [
{
"requirement_type": "comorbidity",
"expected_value": true
}
]
},
{
"exact_snippets": "comorbidity with thyroid dysfunction",
"criterion": "thyroid dysfunction",
"requirements": [
{
"requirement_type": "comorbidity",
"expected_value": true
}
]
},
{
"exact_snippets": "pregnancy",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "haemoglobin levels <10 g/dl",
"criterion": "haemoglobin levels",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": "<",
"value": 10,
"unit": "g/dl"
}
}
]
},
{
"exact_snippets": "haematocrit <30",
"criterion": "haematocrit",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": "<",
"value": 30,
"unit": ""
}
}
]
},
{
"exact_snippets": "anaemia on active pharmacological treatment or receiving blood transfusion or steroids",
"criterion": "anaemia",
"requirements": [
{
"requirement_type": "treatment",
"expected_value": [
"active pharmacological treatment",
"receiving blood transfusion",
"receiving steroids"
]
}
]
}
]
},
{
"line": "4. Being pregnant or nursing, or having used acupuncture for peripheral neuropathy within 6 months prior to study entry;",
"criterions": [
{
"exact_snippets": "Being pregnant",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "nursing",
"criterion": "nursing",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "having used acupuncture for peripheral neuropathy within 6 months prior to study entry",
"criterion": "acupuncture for peripheral neuropathy",
"requirements": [
{
"requirement_type": "usage",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "months"
}
}
]
}
]
},
{
"line": "5. Life expectancy <6 months;",
"criterions": [
{
"exact_snippets": "Life expectancy <6 months",
"criterion": "life expectancy",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": "<",
"value": 6,
"unit": "months"
}
}
]
}
]
},
{
"line": "6. Lymphedema of limbs;",
"criterions": [
{
"exact_snippets": "Lymphedema of limbs",
"criterion": "lymphedema",
"requirements": [
{
"requirement_type": "location",
"expected_value": "limbs"
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [
{
"line": "3. having metastatic or recurrent disease, history of preexisting peripheral neuropa- thy prior to chemotherapy, uncontrolled seizure disorder, unstable cardiac disease or myocardial infarction within 6 months prior to study entry;",
"criterions": [
{
"exact_snippets": "having metastatic or recurrent disease",
"criterion": "disease status",
"requirements": [
{
"requirement_type": "presence",
"expected_value": [
"metastatic",
"recurrent"
]
}
]
},
{
"exact_snippets": "history of preexisting peripheral neuropathy prior to chemotherapy",
"criterion": "peripheral neuropathy",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
},
{
"exact_snippets": "uncontrolled seizure disorder",
"criterion": "seizure disorder",
"requirements": [
{
"requirement_type": "control",
"expected_value": "uncontrolled"
}
]
},
{
"exact_snippets": "unstable cardiac disease",
"criterion": "cardiac disease",
"requirements": [
{
"requirement_type": "stability",
"expected_value": "unstable"
}
]
},
{
"exact_snippets": "myocardial infarction within 6 months prior to study entry",
"criterion": "myocardial infarction",
"requirements": [
{
"requirement_type": "time since event",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "months"
}
}
]
}
]
}
],
"failed_miscellaneous": []
}